Web Box 11.2 Pharmacology in Action: Opiate Bioassay

Bioassays are important and classic tools of pharmacology that provide relatively quick and inexpensive tests of agonist–receptor activity on a biological response. The assays generally measure a simple response in a tissue that is in its native functional state rather than a highly modified (e.g., homogenized cells) nonphysiological condition. Such measures are often used to demonstrate the biological relevance of a newly identified receptor protein. Under ideal conditions, receptor binding and biological response should be measured in the same simple, intact system before disruptive procedures are performed on the cells.

The most accurate bioassay to measure opioid activity was developed by a pioneer in opioid research, Hans Kosterlitz (Kosterlitz et al., 1970). The guinea pig intestinal muscle (ileum) and associated neuronal connections are dissected and maintained in a physiological solution. The muscle is fastened at each end to maintain a fixed tension, so that when the neurons are electrically stimulated, the muscle twitch can be recorded on a polygraph. The twitch is inhibited by opiate drugs, which inhibit the release of neurotransmitter from the stimulated nerves. This inhibition can be blocked by naloxone (Figure 1), which shows that opiate receptors are involved. Further, the magnitude of the twitch inhibition is closely correlated with receptor binding potency. In addition, Kosterlitz and Waterfield (1975) showed that the naloxone-reversible twitch inhibition is almost perfectly correlated with the potency of the opiates to relieve pain in humans (Figure 2). Therefore, it is apparent that a correlation exists between analgesic effects in vivo, muscle-twitch inhibition in the bioassay in vitro, and the ability to bind to opiate receptors. Clearly the bioassay represents a simple and rapid means to screen opioid drugs.

A pair of line graphs depict flow of morphine and naloxone. The X axis measure 1 minute per division. The first graph is for morphine and it starts midway and is full half-way and then drops to half-way and ends at that. The second graph is for both morphine and naloxone; it is the same as the first graph until mid-way after which naloxone starts and ends at the top right.

Figure 1

A pair of line graphs measure relative potency. The X axis measures relative potency in guinea pig ileum and the Y axis measures relative analgesic potency in humans. The two graphs start at about 0.01, move toward the top right, and crisscross each other in the middle. The left graph establishes perfect correlation and the one at the right establishes strong positive correlation. Various substances are marked from the left bottom to the top right as follows: Codeine, Pethidine, and Profadol at the bottom left; Normorphine, Morphine, Methadone, Nalbuphine, Ketobemidone, Oxymorphone, Levorphanol, and Dextromoramide in the middle; and Etorphine at the top right.

Figure 2 A strong positive correlation (shown by the red line) exists between opiate inhibition of guinea pig ileum twitch and analgesic effects in humans. For comparison purposes, the blue line represents a perfect correlation. The values for potency were calculated relative to morphine (morphine = 1). (After Kosterlitz and Waterfield, 1975.).

References

Kosterlitz, H. W., Lydon, R. J., and Watt, A. J. (1970). The effects of adrenaline, noradrenaline, and isoprenaline on inhibitory α- and β-adrenoreceptors in the longitudinal muscle of the guinea pig ileum. Br. J. Pharmacol., 39, 398–413.

Kosterlitz, H. W. and Waterfield, A. A. (1975). The in vitro models in the study of structure-activity relationships of narcotic analgesics. Annu. Rev. Pharmacol., 15, 29–47.

Back to top